Menu
Fechar
hrs4r
 I want to donate

ADELAIDA GARCIA VELASCO

Precision Oncology in Girona
Firma
ADELAIDA GARCIA-VELASCO
Position
Investigador/a Post-doctoral – R2
Postdoctoral Researchers – R2
Projectes
Publicacions

Projectes

Precision Oncology in Girona

CarboSign7 for cancer diagnosis: Biosampling optimization and validation for gastric and lung cancer

Codi oficial: CI23-20369 Start date:30/10/2023 Data fi: 30/10/2025 Investigador/a principal: ADELAIDA GARCIA VELASCO Organisme finançador: FUNDACIÓN BANCARIA LA CAIXA

Publicacions

Vilà-Quintana, L, Fort, E, Pardo, L, Albiol-Quer, MT, Ortiz, MR, Capdevila, M, Feliu, A, Bahí, A, Llirós, M, Aguilar, E, García-Velasco, A, Ginestà, MM, Laquente, B, Pozas, D, Lluansí, A, Pimenoff, VN, Moreno, V, Garcia-Gil, LJ, Duell, EJ, Carreras-Torres, R, Aldeguer, X

Exploring the Associations of Inflammatory and Oxidative Stress Biomarkers with Pancreatic Diseases: An Observational and Mendelian Randomisation Study

Journal of Clinical Medicine, 2024, 13 dx.doi.org/10.3390/jcm13082247
Vilà-Quintana, L, Fort, E, Pardo, L, Albiol-Quer, MT, Ortiz-Duran, MR, Capdevila, M, Feliu, A, Bahi, A, Llirós, M, García-Velasco, A, Ginestá, MM, Laquente, B, Pozas, D, Lluansí, A, Pimenoff, VN, Moreno, V, Garcia-Gil, JL, Duell, EJ, Carreras-Torres, R, Aldeguer, X

The role of oxidative stress in chronic pancreatitis and pancreatic cancer risk

EUROPEAN JOURNAL OF HUMAN GENETICS, 2024, 32, 128-129
Vilà-Quintana L, Fort E, Pardo, L, Albiol-Quer MT, Ortiz MR, Capdevila M, Feliu A, Bahí A, Llirós M, García-Velasco A, Morell Ginestà M, Laquente B, Pozas D, Moreno V, Garcia-Gil LJ, Duell EJ, Pimenoff VN, Carreras-Torres R, Aldeguer X

Metagenomic Study Reveals Phage-Bacterial Interactome Dynamics in Gut and Oral Microbiota in Pancreatic Diseases.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 dx.doi.org/10.3390/ijms252010988
Duran A, Guerrero PE, Ortiz MR, Pérez Del Campo D, Castro E, Garcia-Velasco A, Fort E, De Llorens R, Saldova R, Llop E, Peracaula R

Characterization of Mesothelin Glycosylation in Pancreatic Cancer: Decreased Core Fucosylated Glycoforms in Pancreatic Cancer Patients' Sera

Biomedicines, 2022, 10 dx.doi.org/10.3390/biomedicines10081942
Guerrero PE, Duran A, Ortiz MR, Castro E, Garcia-Velasco A, Llop E, Peracaula R

Microfibril associated protein 4 (MFAP4) is a carrier of the tumor associated carbohydrate sialyl-Lewis x (sLe(x)) in pancreatic adenocarcinoma

JOURNAL OF PROTEOMICS, 2021, 231, 104004-104004 dx.doi.org/10.1016/j.jprot.2020.104004
García-Velasco A, Zacarías-Pons L, Teixidor H, Valeros M, Liñan R, Carmona-Garcia MC, Puigdemont M, Carbajal W, Guardeño R, Malats N, Duell E, Marcos-Gragera R

Incidence and Survival Trends of Pancreatic Cancer in Girona: Impact of the Change in Patient Care in the Last 25 Years

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2020, 17 dx.doi.org/10.3390/ijerph17249538
Fort Culillas, R., Carmona Garcia, C., Osca Geli, G., Marcos-Gragera, R., Puigdemont Guinart, M., Biarnes Costa, J., Lopez-Ben, S., Garcia Velasco, A., Guardeno Sanchez, R.

Incidence and survival of pancreatic neuroendocrine tumours in Girona, Spain

ANNALS OF ONCOLOGY, 2020, 31, 169-169 dx.doi.org/10.1016/j.annonc.2020.04.325
Velasco, AG, Quintana, M, Guinart, MP, Carbajal, W, Sanchez, RG, Anna, V, Nica, A, Villavicencio, A, Vilardell, L, Marcos-Gragera, R

Incidence and trends of biliary tract cancer in Girona: A population-based study from the Girona Cancer Registry (1994-2016)

ANNALS OF ONCOLOGY, 2020, 31, 160-161 dx.doi.org/10.1016/j.annonc.2020.04.298
Laquente B, Macarulla T, Bugés C, Martín M, García C, Pericay C, Merino S, Visa L, Martín T, Pedraza M, Carnero B, Guardeño R, Verdaguer H, Mut A, Vilanova D, García A

Quality of life of patients with metastatic pancreatic adenocarcinoma initiating first-line chemotherapy in routine practice.

BMC PALLIATIVE CARE, 2020, 19, 103-103 dx.doi.org/10.1186/s12904-020-00610-4
Fernández A, Salgado M, García A, Buxò E, Vera R, Adeva J, Jiménez-Fonseca P, Quintero G, Llorca C, Cañabate M, López LJ, Muñoz A, Ramírez P, González P, López C, Reboredo M, Gallardo E, Sanchez-Cánovas M, Gallego J, Guillén C, Ruiz-Miravet N, Navarro-Pérez V, De la Cámara J, Alés-Díaz I, Pazo-Cid RA, Carmona-Bayonas A

Prognostic factors for survival with nab-paclitaxel plus gemcitabine in metastatic pancreatic cancer in real-life practice: the ANICE-PaC study.

Bmc Cancer, 2018, 18, 1185-1185 dx.doi.org/10.1186/s12885-018-5101-3

Formulari de contacte

About IDIBGI!

 menu